Literature DB >> 17551466

17 beta-hydroxysteroid dehydrogenase 3 deficiency in the Mediterranean population.

Ariel Rosler1.   

Abstract

Eighty-five males with 17 beta-HSD3 were identified among a highly inbred Arab population in Israel and 57 studied over a period of 25 years. The founders of this defect originated in the mountainous regions of present Lebanon and Syria, but most of the families now live in Jerusalem, Hebron, the Tel-Aviv area and, in particular, in Gaza, where the frequency of affected males is estimated at 1 in 100 to 150. Affected individuals are born with ambiguity of the external genitalia and reared as females until puberty. Thereafter marked virilization occurs, leading in many cases to the spontaneous adoption of a male gender identity and role. Adults develop a male habitus with abundant body hair and beard and the phallus and testes enlarge to adult proportions. Gender reassignment in infancy was only possible when enough erectile tissue was present at birth and developed into a normal size penis with testosterone. 17 beta-HSD3 deficiency can be reliably diagnosed by endocrine evaluation and mutation analysis. In adults the defect is characterized by markedly increased concentrations of androstenedione (A) with borderline low to normal testosterone (T) levels and a high A/T ratio. 5a-dihydrotestosterone (DHT) concentrations are moderately decreased, normal or high and dehydroepiandrosterone (DHEA) levels are high. The estrogen pathway is also impaired, even though both estrone (E-1) and estradiol-17 beta (E-2) levels are high. Children have low basal levels of all androgens, but the defect may be demonstrated after prolonged stimulation with human chorionic gonadotropin (HCG). LH and FSH levels are very high after puberty and normal in childhood. 17 beta-HSD3 isozyme is encoded by the chromosome 9q22 17 beta-HSD3 gene and expressed exclusively in testes. A point mutation in exon 3, codon 80 of the 17 beta-HSD3 gene, R80Q, caused by a single base substitution from CGG ( arginine) to CAG ( glutamine) was identified in both alleles of 24 individuals from 9 extended Arab families from Gaza, Jerusalem and Lod-Ramle. Twenty-one homozygote males (46,XY) were MPH with testicular 17 beta-HSD3 deficiency whereas the three homozygote females (46,XX) were asymptomatic, had normal internal and external genitalia, normal sexual development and revealed no biochemical evidence of 17 beta-HSD3 deficiency. The molecular pattern is compatible with an autosomal recessive mode of inheritance, sex dependent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17551466

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  9 in total

1.  A Novel Mutation Causing 17-β-Hydroxysteroid Dehydrogenase Type 3 Deficiency in an Omani Child: First Case Report and Review of Literature.

Authors:  Aisha Al-Sinani; Waad-Allah S Mula-Abed; Manal Al-Kindi; Ghariba Al-Kusaibi; Hanan Al-Azkawi; Nahid Nahavandi
Journal:  Oman Med J       Date:  2015-03

Review 2.  Clinical, endocrine, and molecular findings in 17beta-hydroxysteroid dehydrogenase type 3 deficiency.

Authors:  M F Faienza; L Giordani; M Delvecchio; L Cavallo
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

Review 3.  Concepts and Updates in the Evaluation and Diagnosis of Common Disorders of Sexual Development.

Authors:  Amar Y Rawal; Paul F Austin
Journal:  Curr Urol Rep       Date:  2015-12       Impact factor: 3.092

Review 4.  Leucippus, either male or death: a case of sex reversal by divine intervention.

Authors:  Georgios K Markantes; Konstantina Barouti; Maria I Stamou; Neoklis A Georgopoulos
Journal:  Hormones (Athens)       Date:  2020-09-15       Impact factor: 2.885

5.  46,XY Disorder of Sex Development due to 17-Beta Hydroxysteroid Dehydrogenase Type 3 Deficiency in an Infant of Greek Origin.

Authors:  Assimina Galli-Tsinopoulou; Anastasios Serbis; Eleni P Kotanidou; Eleni Litou; Vaia Dokousli; Konstantina Mouzaki; Pavlos Fanis; Vassos Neocleous; Nicos Skordis
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-07-24

6.  46,XY Sex Development Defect due to a Novel Homozygous (Splice Site) c.673_1G>C Variation in the HSD17B3 Gene: Case Report

Authors:  Nurdan Çiftci; Leman Kayaş; Emine Çamtosun; Ayşehan Akıncı
Journal:  J Clin Res Pediatr Endocrinol       Date:  2021-01-04

7.  A Novel Compound Heterozygous Mutation of HSD17B3 Gene Identified in a Patient With 46,XY Difference of Sexual Development.

Authors:  Carlotta Cocchetti; Fulvia Baldinotti; Alessia Romani; Jiska Ristori; Francesca Mazzoli; Linda Vignozzi; Mario Maggi; Alessandra Daphne Fisher
Journal:  Sex Med       Date:  2022-05-17       Impact factor: 2.523

8.  Severe Undervirilisation in a 46,XY Case Due to a Novel Mutation in HSD17B3 Gene.

Authors:  Ayfer Alikaşifoğlu; Doğuş Vurallı; Olaf Hiort; Nazlı Gönç; Alev Özön; Nurgün Kandemir
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-09

9.  Detection of 46, XY Disorder of Sex Development (DSD) Based on Plasma Cell-Free DNA and Targeted Next-Generation Sequencing.

Authors:  Luigia De Falco; Carmelo Piscopo; Rossana D'Angelo; Eloisa Evangelista; Teresa Suero; Roberto Sirica; Raffaella Ruggiero; Giovanni Savarese; Antonella Di Carlo; Giulia Furino; Ciro Scarpato; Antonio Fico
Journal:  Genes (Basel)       Date:  2021-11-25       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.